Page 2 - Prima System News Today

👏 Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMDPixium Vision announces F

Pixium Vision announces its cash position at 31 December 2022 and provides an update on its activities. Paris, 14 February 2023 - 21:00 CET - Pixium Vision SA (Euronext Growth Paris

Investegate announcements from Pixium Vision, Pixium Vision announces its cash position at 31 December 2022 and provides an update on its activities

Extraordinary General Meeting of February 15, 2023: Notice of publication of the preparatory documents Paris, France, January 27, 2023 – 6.00 pm CET –...

Pixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024 38 patients

Investegate announcements from Pixium Vision, Pixium Vision to host open house event for investors on October 13th 2022 from 5 pm

Investegate announcements from Pixium Vision, Pixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022

Pixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022 The target number of 38 patients have

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.